zoledronic acid has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Finch, ER; Janke, LJ; Jenkins, DA; Karol, SE; Kim, J; Liu, Y; Payton, MA; Relling, MV | 1 |
| Cheung, LC; Chua, GA; Foley, B; Ford, J; He, B; Howlett, M; Hughes, AM; Kees, UR; Kotecha, RS; Mullighan, CG; Oommen, J; Singh, S; Skut, P; Tickner, J; Wells, JE | 1 |
| Dalla-Pozza, L; Little, DG; Munns, CF; Padhye, B | 1 |
| Efthymiadou, A; Gkentzi, D; Karana-Ginopoulou, A; Kolyva, S; Varvarigou, A | 1 |
| Dalla-Pozza, L; Little, D; Munns, C; Padhye, B | 1 |
| Ashihara, E; Fujiyama, Y; Kamitsuji, Y; Kawata, E; Kimura, S; Kuroda, J; Maekawa, T; Ottmann, OG; Sato, K; Segawa, H; Yokota, A; Yuasa, T | 1 |
1 review(s) available for zoledronic acid and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Child; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Zoledronic Acid | 2014 |
1 trial(s) available for zoledronic acid and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Imidazoles; Incidence; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Zoledronic Acid | 2016 |
4 other study(ies) available for zoledronic acid and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Imidazoles; Mice; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; X-Ray Microtomography; Zoledronic Acid | 2021 |
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Resorption; Cell Line; HEK293 Cells; Hematopoiesis; Humans; Lymphopoiesis; Mice; Mice, Inbred C57BL; Osteoclasts; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RANK Ligand; Tumor Microenvironment; Zoledronic Acid | 2018 |
Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.
Topics: Adolescent; Arthralgia; Arthroplasty; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Humans; Imidazoles; Lymphoma; Male; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Retrospective Studies; Time Factors; Zoledronic Acid | 2013 |
Zoledronate synergises with imatinib mesylate to inhibit Ph primary leukaemic cell growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Diphosphonates; Drug Synergism; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Models, Animal; Neoplasm Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tumor Cells, Cultured; Zoledronic Acid | 2005 |